Yuan Dong Bio announced it has received a drug registration certificate from China's National Medical Products Administration for its Vitamin K1 injection. This approval signifies that the drug has passed the generic drug consistency evaluation. The injection is intended to treat vitamin K deficiency bleeding and related conditions. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON The cluster reports on a drug registration certificate being awarded for a pharmaceutical product. [lever_c_demoted from research: ic=1 ai=0.1]